EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations

Åsa Krantz, Juan Jesus Carrero, Yuanhang Yang, Lovisa Schalin, Josefin Lysell, Faizan Mazhar

Acta Dermato-Venereologica · 15.06.2023 · 103 · adv6505

DOI: 10.2340/actadv.v103.6505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 15.06.2023. Verfasst von Åsa Krantz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology Section, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Biological Products, Psoriasis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited information exists regarding treatment of patients with psoriasis/psoriatic arthritis in primary care. The aim of this study is to assess treatment patterns, adherence, persistence, and compliance in newly diagnosed patients with psoriasis/psoriatic arthritis from 2012 to 2018 in Stockholm, Sweden. In addition, laboratory monitoring before initiation of treatment and at recommended intervals was quantified for patients prescribed methotrexate or biologics. A total of 51,639 individuals were included, with 39% initiating treatment with topical corticosteroids and < 5% receiving systemic treatment within 6 months post-diagnosis. During a median (interquartile range) follow-up of 7 (4–8) years, 18% of patients received systemic treatments at some point. Overall, 5-year persistence rates were 32%, 45% and 19% for methotrexate, biologics, and other systemic treatments, respectively. Pre-initiation laboratory tests, as recommended by guidelines, were performed in approximately 70% and 62% of methotrexate and biologics users, respectively. Follow-up monitoring at recommended time intervals occurred in 14–20% and 31–33% of patients prescribed methotrexate and biologics, respectively. These findings highlight gaps in the pharmacological care of patients with psoriasis/psoriatic arthritis, including suboptimal adherence/persistence and inadequate laboratory monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticBiological ProductsPsoriasisHumansAdministration, CutaneousMethotrexateMedication Adherence

Substanzen

Biological ProductsMethotrexate

Autor:innen und Institutionen

  • Dermatology and Venereology Section, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden.
  • Amgen Sweden. lschalin@amgen.com.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden. faizan.mazhar@ki.se.

Zitieren

APA

Krantz, Å., Carrero, J. J., Yang, Y., Schalin, L., Lysell, J., & Mazhar, F. (2023). Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations. Acta Dermato-Venereologica, 103, adv6505. https://doi.org/10.2340/actadv.v103.6505

Vancouver

Krantz Å, Carrero JJ, Yang Y, Schalin L, Lysell J, Mazhar F. Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations. Acta Dermato-Venereologica. 2023;103:adv6505. doi:10.2340/actadv.v103.6505

BibTeX
@article{Krantz2023,
  author = {Krantz, Åsa and Carrero, Juan Jesus and Yang, Yuanhang and Schalin, Lovisa and Lysell, Josefin and Mazhar, Faizan},
  title = {Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations},
  journal = {Acta Dermato-Venereologica},
  year = {2023},
  volume = {103},
  pages = {adv6505},
  doi = {10.2340/actadv.v103.6505}
}
Kostenlos starten →